| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 10/12/2006 | WO2006106052A1 Pyrazoles |
| 10/12/2006 | WO2006105979A1 Sulfonylpyrroles as histone deacetylase inhibitors |
| 10/12/2006 | WO2006105865A1 Indazole squaric acid derivatives as chk1-, chk2- and sgk- inhibitors |
| 10/12/2006 | WO2006105862A1 Substituted n-[pyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators |
| 10/12/2006 | WO2006082412A3 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
| 10/12/2006 | WO2006078283A3 Quinoxaline inhibitors of hedgehog signalling |
| 10/12/2006 | WO2006072589A3 Disubstituted ureas as kinase inhibitors |
| 10/12/2006 | WO2006066879A3 Compounds with kv4 ion channel activity |
| 10/12/2006 | WO2006063578A3 Method for production of candesartan |
| 10/12/2006 | WO2006010591A3 Quinazoline derivatives |
| 10/12/2006 | WO2005123703A3 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 10/12/2006 | WO2005023760A3 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 10/12/2006 | US20060229455 Bicyclic [3.1.0.] heteroaryl amides as type 1 glycine transport inhibitors |
| 10/12/2006 | US20060229447 Constrained compounds as CGRP-receptor antagonists |
| 10/12/2006 | US20060229350 Losartan potassium crystalline form alpha |
| 10/12/2006 | US20060229336 HIV, acquired immune deficiency syndrome (AIDS); 1-(8-{2-[1-(2,2-Dimethylpropanoyl)-4-phenylpiperidin-4-yl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1H-benzimidazole |
| 10/12/2006 | US20060229335 Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a |
| 10/12/2006 | US20060229330 4-aminopyrimidine-5-one derivatives |
| 10/12/2006 | US20060229326 For therapy and prophylaxis of diseases which are associated with the modulation of cannabinoid receptors (CB1), such as obesity |
| 10/12/2006 | US20060229324 Quinazolin-4-one derivatives |
| 10/12/2006 | US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists |
| 10/12/2006 | US20060229313 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 10/12/2006 | US20060229312 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 10/12/2006 | US20060229311 Isatine derivatives with neurotrophic activity |
| 10/12/2006 | US20060229307 partial antagonists and partial agonists of vanilloid-1 receptor (VR1); N-(4-trifluoromethylphenyl)-2-(3-trifluoromethyl-2-pyridinyl)pyrido[2,3-d]pyridazin-5-amine; antiinflammatory and analgesic agent |
| 10/12/2006 | US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 10/12/2006 | US20060229297 (THIO) Carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists |
| 10/12/2006 | US20060229296 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss |
| 10/12/2006 | US20060229289 2-(2-Methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide, aka veliparib, for example; poly(ADP-ribose)polymerase inhibitors; antiinflammatory, antitumor agents; Parkinson's disease |
| 10/12/2006 | US20060229254 Compounds having prolyl oligopeptidase inhibitory activity |
| 10/12/2006 | US20060229205 Herbicidal heterocycles |
| 10/12/2006 | CA2603939A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors |
| 10/12/2006 | CA2603478A1 Indazole squaric acid derivatives as chk1-, chk2- and sgk- inhibitors |
| 10/12/2006 | CA2603398A1 Sulfonylpyrroles as histone deacetylase inhibitors |
| 10/12/2006 | CA2603250A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors |
| 10/12/2006 | CA2603169A1 Substituted n-[pyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators |
| 10/11/2006 | EP1710793A1 Metal chelate compounds and high capacity optical recording medium using the compounds |
| 10/11/2006 | EP1709051A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 10/11/2006 | EP1709037A2 Hiv protease inhibiting sulfonamides |
| 10/11/2006 | EP1709034A2 An improved process for the synthesis of losartan potassium |
| 10/11/2006 | EP1709033A1 New polymorphic forms of ondansetron, processes for preparing them, pharmaceutical compositions containing them and their use as antiemetics |
| 10/11/2006 | EP1709032A2 Crystalline forms of rizatriptan benzoate |
| 10/11/2006 | EP1709031A1 Chrysogenazine obtained from fungus penicillium chrysogenum having antibacterial activity |
| 10/11/2006 | EP1709030A1 Indolylmaleimide derivatives |
| 10/11/2006 | EP1709011A1 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 10/11/2006 | EP1709009A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 10/11/2006 | EP1709007A1 N-4-(6-(heteo)aryl-pyrimidin-4-ylaminophenyl)-benzenesulfonamides as kinase inhibitors |
| 10/11/2006 | EP1709006A1 Benzimidazole derivatives |
| 10/11/2006 | EP1708997A1 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions |
| 10/11/2006 | EP1708996A1 Fused heteroyral derivatives for use as p38 kinase inhibitors |
| 10/11/2006 | EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 10/11/2006 | EP1551803B1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 10/11/2006 | EP1363903B1 Indole derivatives and their use as gnrh antagonists |
| 10/11/2006 | EP1107959B1 Quinazoline derivatives as medicaments |
| 10/11/2006 | CN1845924A Arylamine-substituted quinazolinone compounds |
| 10/11/2006 | CN1845921A Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as DPP-IV inhibitors |
| 10/11/2006 | CN1845920A 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 10/11/2006 | CN1845918A Pyrimidines useful as modulators of voltage-gated ion channels |
| 10/11/2006 | CN1845909A Quinoxaline derivatives as neutrophil elastase inhibitors and their use |
| 10/11/2006 | CN1845908A 5-substituted quinazolinone derivatives |
| 10/11/2006 | CN1845901A CCK-1 receptor modulators |
| 10/11/2006 | CN1845900A Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 10/11/2006 | CN1845734A Benzimidazole derivatives and their use as protein kinases inhibitors |
| 10/11/2006 | CN1845733A Tgf-beta gene expression inhibitor |
| 10/11/2006 | CN1279026C Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 10/10/2006 | US7119209 Process for preparing indolinone derivatives |
| 10/10/2006 | US7119204 phenanthroline compounds that exhibit electroluminescence, photoluminescence and/or photosensitivity, used in electrical apparatus such as organic light emitting diodes |
| 10/10/2006 | US7119201 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 10/10/2006 | US7119179 Melting and then pyrrolysis of 4,4',6,6'-tetra(azido)azo-1,3,5-triazine (TAAT) to form the carbon nitrides, C2N3 and C3N5, with varying density, texture, and morphology |
| 10/10/2006 | US7119115 For therapy of treating tumors or cancerous cells |
| 10/10/2006 | US7119111 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
| 10/10/2006 | US7119104 Alpha-(oxy-, sulfo- or amino-)[3-(imidazolyl, oxazolyl or thiazolyl)alkylene(indazolyl, benzisoxazolyl or benzisothiazolyl)]acetic acids, esters or alkali salts |
| 10/10/2006 | US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases |
| 10/10/2006 | US7119097 2-(4,6-dimethoxypyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropionic acid; formulations for oral, parenteral, or nasopharyngeal delivery; endothelin receptor antagonist |
| 10/10/2006 | US7119093 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition |
| 10/10/2006 | US7119090 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases, enzyme inhibitors |
| 10/10/2006 | US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis |
| 10/10/2006 | US7119084 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders |
| 10/10/2006 | US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 10/10/2006 | US7118839 Charge transport compound containing at least two carbazolecarboxaldehyde substituted- hydrazone groups |
| 10/10/2006 | US7118811 Materials for light emitting devices consisting of novel compounds and light emitting devices using the same |
| 10/10/2006 | US7118760 esters with with C16 to C50 alcohols and/or siloxane derivatives; increased water resistance, increased stability, improved permanence |
| 10/10/2006 | CA2418778C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
| 10/10/2006 | CA2352554C Substituted benzimidazoles and their use as parp inhibitors |
| 10/10/2006 | CA2347939C Composition for the treatment of rheumatism, hepatitis or pancreatitis |
| 10/10/2006 | CA2255951C Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 10/10/2006 | CA2225366C Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
| 10/10/2006 | CA2158862C Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
| 10/05/2006 | WO2006105262A1 HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl |
| 10/05/2006 | WO2006105081A2 Pharmacokinetically improved compounds |
| 10/05/2006 | WO2006105056A2 Insecticidal 2,4-diaminoquinazolines and related derivatives |
| 10/05/2006 | WO2006104713A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
| 10/05/2006 | WO2006104280A1 Prophylactic/therapeutic agent for diabetes |
| 10/05/2006 | WO2006104008A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 10/05/2006 | WO2006103068A1 A synthesis of 4-bromomethyl-2'-formylbiphenyl and 4-bromomethyl-2'- hydroxymethylbiphenyl and its use in preparation of angiotensin ii antagonists |
| 10/05/2006 | WO2006102998A1 Substituted tetrahydroisochinolines as mmp inhibitors, related production method and use as medicine |
| 10/05/2006 | WO2006102760A1 Inhibitors of histone deacetylase |
| 10/05/2006 | WO2006074799A3 5-pyrrolidinylsulfonyl isatin derivatives |
| 10/05/2006 | WO2006072458A3 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 10/05/2006 | WO2006071609A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |